MedTrace Logo

Outcome of Cardiomyopathic Adults Admission in ICU.

NCT05567445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-10-06

No results posted yet for this study

Summary

To study the outcome of the cardiac function, and clinical status of the patiants with cardiomyopathy who are admitted in the I.C.U.

Conditions

  • Cardiomyopathies

Interventions

DIAGNOSTIC_TEST

Echocardiography, CBC, Liver function, kideny function

Echocardiography, AST, ALT, UREA,CREAT. , CBC,may blood cultures.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed Mohammed Aly Obied-Allah, Ass.prof. · Assiut University

  • NoorEldeen Abd-El Azeem M.EL- Hefny, Prof · Assiut University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-09-30
Completion
2024-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05567445 on ClinicalTrials.gov